PL2496720T3 - Nieinwazyjna diagnoza odrzucenia przeszczepu u pacjentów z przeszczepem narządu - Google Patents
Nieinwazyjna diagnoza odrzucenia przeszczepu u pacjentów z przeszczepem narząduInfo
- Publication number
- PL2496720T3 PL2496720T3 PL10829142T PL10829142T PL2496720T3 PL 2496720 T3 PL2496720 T3 PL 2496720T3 PL 10829142 T PL10829142 T PL 10829142T PL 10829142 T PL10829142 T PL 10829142T PL 2496720 T3 PL2496720 T3 PL 2496720T3
- Authority
- PL
- Poland
- Prior art keywords
- graft rejection
- organ transplant
- transplant patients
- invasive diagnosis
- invasive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28067409P | 2009-11-06 | 2009-11-06 | |
PCT/US2010/055604 WO2011057061A1 (en) | 2009-11-06 | 2010-11-05 | Non-invasive diagnosis of graft rejection in organ transplant patients |
EP10829142.8A EP2496720B1 (en) | 2009-11-06 | 2010-11-05 | Non-invasive diagnosis of graft rejection in organ transplant patients |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2496720T3 true PL2496720T3 (pl) | 2021-01-11 |
Family
ID=43970349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10829142T PL2496720T3 (pl) | 2009-11-06 | 2010-11-05 | Nieinwazyjna diagnoza odrzucenia przeszczepu u pacjentów z przeszczepem narządu |
Country Status (13)
Country | Link |
---|---|
US (14) | US8703652B2 (pl) |
EP (2) | EP3719140A1 (pl) |
JP (4) | JP2013509883A (pl) |
CN (1) | CN102712954A (pl) |
AU (5) | AU2010315084A1 (pl) |
CA (1) | CA2779750C (pl) |
DK (1) | DK2496720T3 (pl) |
ES (1) | ES2821500T3 (pl) |
GB (1) | GB2488289A (pl) |
HU (1) | HUE052213T2 (pl) |
PL (1) | PL2496720T3 (pl) |
PT (1) | PT2496720T (pl) |
WO (1) | WO2011057061A1 (pl) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
EP2473638B1 (en) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
CA2779750C (en) | 2009-11-06 | 2019-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive diagnosis of graft rejection in organ transplant patients |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
WO2011146632A1 (en) | 2010-05-18 | 2011-11-24 | Gene Security Network Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
JP6328934B2 (ja) | 2010-12-22 | 2018-05-23 | ナテラ, インコーポレイテッド | 非侵襲性出生前親子鑑定法 |
AU2011358564B9 (en) * | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
US10072294B2 (en) * | 2011-02-22 | 2018-09-11 | City Of Hope | Ultra-high sensitive monitoring of early transplantation failure |
WO2013043922A1 (en) * | 2011-09-22 | 2013-03-28 | ImmuMetrix, LLC | Compositions and methods for analyzing heterogeneous samples |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
CA2849354C (en) | 2011-09-26 | 2021-11-09 | Preanalytix Gmbh | Stabilisation and isolation of extracellular nucleic acids |
ES2687126T3 (es) * | 2011-09-26 | 2018-10-23 | Qiagen Gmbh | Estabilización y aislamiento de ácidos nucleicos extracelulares |
ES2646212T3 (es) * | 2011-10-07 | 2017-12-12 | Murdoch Childrens Research Institute | Ensayo de diagnóstico para determinar el estado de trasplante de tejidos |
WO2013159035A2 (en) | 2012-04-19 | 2013-10-24 | Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free dna |
KR101890466B1 (ko) * | 2012-07-24 | 2018-08-21 | 내테라, 인코포레이티드 | 고도의 다중 pcr 방법 및 조성물 |
US10724074B2 (en) | 2012-09-25 | 2020-07-28 | Qiagen Gmbh | Stabilisation of biological samples |
CN105190656B (zh) | 2013-01-17 | 2018-01-16 | 佩索纳里斯公司 | 用于遗传分析的方法和系统 |
CN105189748B (zh) | 2013-03-15 | 2021-06-08 | 血统生物科学公司 | 测序免疫组库的方法 |
GB2584364A (en) | 2013-03-15 | 2020-12-02 | Abvitro Llc | Single cell bar-coding for antibody discovery |
EP3447141B1 (en) * | 2013-03-18 | 2020-08-05 | PreAnalytiX GmbH | Stabilisation of biological samples |
CN105164258B (zh) | 2013-03-18 | 2021-05-18 | 凯杰有限公司 | 细胞外核酸的稳定化和分离 |
CN105283557A (zh) * | 2013-05-08 | 2016-01-27 | 豪夫迈·罗氏有限公司 | 使用下一代系统深度测序hla 基因扩增子定量分析混合物来非侵入性早期检测实体器官移植物排斥反应 |
WO2015031689A1 (en) | 2013-08-30 | 2015-03-05 | Personalis, Inc. | Methods and systems for genomic analysis |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
WO2015051275A1 (en) | 2013-10-03 | 2015-04-09 | Personalis, Inc. | Methods for analyzing genotypes |
WO2015069933A1 (en) * | 2013-11-06 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Circulating cell-free dna for diagnosis of transplant rejection |
IL285106B (en) * | 2013-11-07 | 2022-09-01 | Univ Leland Stanford Junior | Clean nucleic acids are suitable for analyzing the human microbiome and its parts |
CN106461679B (zh) | 2014-03-12 | 2018-10-09 | 西奈山伊坎医学院 | 鉴定处于慢性损伤风险的肾异体移植物接受者的方法 |
US11767559B2 (en) * | 2014-03-14 | 2023-09-26 | Caredx, Inc. | Methods of monitoring immunosuppressive therapies in a transplant recipient |
EP3792366A1 (en) * | 2014-04-04 | 2021-03-17 | Affymetrix, Inc. | Improved compositions and methods for molecular inversion probe assays |
CN113774132A (zh) | 2014-04-21 | 2021-12-10 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
US11572587B2 (en) | 2014-06-26 | 2023-02-07 | Icahn School Of Medicine At Mount Sinai | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets |
WO2016001411A1 (en) * | 2014-07-03 | 2016-01-07 | Multiplicom N.V. | Methods for non-invasive detection of transplant health or rejection |
US20160017421A1 (en) * | 2014-07-16 | 2016-01-21 | Roche Molecular Systems | Non-invasive early detection of solid organ transplant rejection by quantitative analysis of hla gene amplicons |
SG11201702060VA (en) | 2014-09-15 | 2017-04-27 | Abvitro Inc | High-throughput nucleotide library sequencing |
WO2016070131A1 (en) | 2014-10-30 | 2016-05-06 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
KR101850437B1 (ko) * | 2015-04-14 | 2018-04-20 | 이원다이애그노믹스(주) | 차세대 염기서열 분석기법을 이용한 장기 이식 거부 반응 예측 방법 |
AU2016255573A1 (en) * | 2015-04-30 | 2017-12-21 | The Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
EP3298169A4 (en) | 2015-05-18 | 2018-10-24 | Karius Inc. | Compositions and methods for enriching populations of nucleic acids |
EP3377645B1 (en) | 2015-11-20 | 2023-10-04 | Qiagen GmbH | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids |
CA3014070C (en) | 2016-03-25 | 2023-03-14 | Karius, Inc. | Synthetic nucleic acid spike-ins |
US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
JP2019534016A (ja) * | 2016-11-02 | 2019-11-28 | ザ メディカル カレッジ オブ ウィスコンシン,インコーポレイテッドThe Medical College of Wisconsin, Inc. | 全および特異的な無細胞dnaを使用しリスクを評価するための方法 |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
EP3556861A4 (en) | 2016-12-19 | 2019-11-20 | Osaka University | METHOD FOR IN VITRO EARLY DIAGNOSIS OF POST-GANTRANSPLANT ANTIBODY-EMBOSSED PUNCHING USING A IGM-TYPE MEMORY B CELL CELL DIFFERENTIATION CULTURING SYSTEM |
WO2018187226A1 (en) * | 2017-04-04 | 2018-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Quantification of transplant-derived circulating cell-free dna in the absence of a donor genotype |
US10697008B2 (en) | 2017-04-12 | 2020-06-30 | Karius, Inc. | Sample preparation methods, systems and compositions |
CA3067637A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
WO2018237078A1 (en) * | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | ASSESSMENT OF CONDITIONS IN GRAFT SUBJECTS USING SPECIFIC ACELLULAR DNA FROM A DONOR |
EP3652749A4 (en) | 2017-07-14 | 2021-03-24 | The Regents of The University of California | NEW PROCESSES FOR PREDICTING THE RISK OF GRAFT REJECTION |
US20200299677A1 (en) | 2017-10-27 | 2020-09-24 | Juno Diagnostics, Inc. | Devices, systems and methods for ultra-low volume liquid biopsy |
WO2019118926A1 (en) * | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
WO2019116393A1 (en) | 2017-12-15 | 2019-06-20 | Acrannolife Genomics Pvt. Ltd. | A non-invasive method for monitoring transplanted organ status in organ-transplant recipients |
CA3082601A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
BR112020019972A2 (pt) | 2018-04-16 | 2021-01-05 | Icahn School Of Medicine At Mount Sinai | Métodos para identificar um receptor de aloenxerto renal e para identificar um receptor de aloenxerto renal em risco de rejeição aguda do aloenxerto antes do transplante, kit para identificar receptores de aloenxerto renal e método para selecionar um paciente com aloenxerto renal |
US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
WO2019241526A1 (en) * | 2018-06-14 | 2019-12-19 | The Trustees Of Columbia University In The City Of New York | Genetic and serological assays for improved donor/recipient matching |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CA3107467A1 (en) * | 2018-09-07 | 2020-03-12 | Sequenom, Inc. | Methods, and systems to detect transplant rejection |
WO2020076957A1 (en) * | 2018-10-09 | 2020-04-16 | Tai Diagnostics, Inc. | Cell lysis assay for cell-free dna analysis |
US20220073989A1 (en) * | 2018-12-20 | 2022-03-10 | The Regents Of The University Of California | Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA |
US11017179B2 (en) * | 2018-12-28 | 2021-05-25 | Open Text Sa Ulc | Real-time in-context smart summarizer |
CA3128894A1 (en) * | 2019-02-19 | 2020-08-27 | Sequenom, Inc. | Compositions, methods, and systems to detect hematopoietic stem cell transplantation status |
WO2020206269A1 (en) * | 2019-04-03 | 2020-10-08 | The Medical College Of Wisconsin, Inc. | Transplant patient monitoring with cell-free dna |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
US11003840B2 (en) | 2019-06-27 | 2021-05-11 | Open Text Corporation | System and method for in-context document composition using subject metadata queries |
US11423114B2 (en) | 2019-11-07 | 2022-08-23 | Open Text Holdings, Inc. | Content management systems for providing automated generation of content suggestions |
US11216521B2 (en) | 2019-11-07 | 2022-01-04 | Open Text Holdings, Inc. | Content management methods for providing automated generation of content suggestions |
WO2021207244A1 (en) * | 2020-04-06 | 2021-10-14 | The Medical College Of Wisconsin, Inc. | Methods for assessing the severity of, and for inhibiting, pro-inflammatory responses with total cell-free dna |
Family Cites Families (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US544732A (en) | 1895-08-20 | James a | ||
US4466467A (en) | 1979-06-18 | 1984-08-21 | Tolliver Wilbur E | Stackable stirrup mat |
US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
US5100899A (en) | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
US5432054A (en) | 1994-01-31 | 1995-07-11 | Applied Imaging | Method for separating rare cells from a population of cells |
US5670347A (en) * | 1994-05-11 | 1997-09-23 | Amba Biosciences Llc | Peptide-mediated gene transfer |
US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
US5520584A (en) | 1994-11-17 | 1996-05-28 | Thomas G. Brown, III | Bicycle chain cover |
US5686767A (en) | 1994-12-29 | 1997-11-11 | Thomson Consumer Electronics, Inc. | Apportioning minimal standby power |
IL139728A (en) | 1995-01-09 | 2003-06-24 | Penwest Pharmaceuticals Compan | Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient |
US6455254B1 (en) | 1995-07-18 | 2002-09-24 | Diversa Corporation | Sequence based screening |
US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US6969488B2 (en) | 1998-05-22 | 2005-11-29 | Solexa, Inc. | System and apparatus for sequential processing of analytes |
USRE39920E1 (en) * | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
US6492144B1 (en) | 1997-05-30 | 2002-12-10 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
AU9683098A (en) | 1997-10-03 | 1999-04-27 | Trustees Of Columbia University In The City Of New York, The | Method for predicting transplant rejection |
ATE423314T1 (de) | 1998-06-24 | 2009-03-15 | Illumina Inc | Dekodierung von matrixartig-angeordneten sensoren durch mikropartikel |
US20030022207A1 (en) | 1998-10-16 | 2003-01-30 | Solexa, Ltd. | Arrayed polynucleotides and their use in genome analysis |
US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
FR2782730B1 (fr) | 1998-08-25 | 2002-05-17 | Biocom Sa | Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede |
US7612020B2 (en) | 1998-12-28 | 2009-11-03 | Illumina, Inc. | Composite arrays utilizing microspheres with a hybridization chamber |
US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
US6846460B1 (en) | 1999-01-29 | 2005-01-25 | Illumina, Inc. | Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses |
US20050191698A1 (en) | 1999-04-20 | 2005-09-01 | Illumina, Inc. | Nucleic acid sequencing using microsphere arrays |
US6355431B1 (en) | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
DE19920370C1 (de) | 1999-05-04 | 2001-01-25 | Mannesmann Vdo Ag | Verfahren zur Bestimmung der Gefriertemperatur einer Flüssigkeit und eine hierfür bestimmte Vorrichtung |
US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
CA2374596A1 (en) | 1999-05-20 | 2000-11-30 | Illumina, Inc. | Method and apparatus for retaining and presenting at least one microsphere array to solutions and/or to optical imaging systems |
US6544732B1 (en) | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
WO2000075373A2 (en) | 1999-05-20 | 2000-12-14 | Illumina, Inc. | Combinatorial decoding of random nucleic acid arrays |
CA2382436C (en) | 1999-08-30 | 2011-05-17 | Illumina, Inc. | Methods for improving signal detection from an array |
US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US6505125B1 (en) | 1999-09-28 | 2003-01-07 | Affymetrix, Inc. | Methods and computer software products for multiple probe gene expression analysis |
EP1218543A2 (en) | 1999-09-29 | 2002-07-03 | Solexa Ltd. | Polynucleotide sequencing |
ATE527053T1 (de) | 1999-12-13 | 2011-10-15 | Illumina Inc | Syntheseeinrichtung für oligonukleotide unter nutzung von fliehkraft |
US6582938B1 (en) | 2001-05-11 | 2003-06-24 | Affymetrix, Inc. | Amplification of nucleic acids |
GB0002389D0 (en) | 2000-02-02 | 2000-03-22 | Solexa Ltd | Molecular arrays |
US6913884B2 (en) | 2001-08-16 | 2005-07-05 | Illumina, Inc. | Compositions and methods for repetitive use of genomic DNA |
AU3806701A (en) | 2000-02-07 | 2001-08-14 | Illumina Inc | Nucleic acid detection methods using universal priming |
JP2003521252A (ja) | 2000-02-07 | 2003-07-15 | イルミナ インコーポレイテッド | ユニバーサルプライミングを用いる核酸検出方法 |
US6770441B2 (en) | 2000-02-10 | 2004-08-03 | Illumina, Inc. | Array compositions and methods of making same |
WO2002027029A2 (en) | 2000-09-27 | 2002-04-04 | Lynx Therapeutics, Inc. | Method for determining relative abundance of nucleic acid sequences |
US6753137B2 (en) | 2001-01-31 | 2004-06-22 | The Chinese University Of Hong Kong | Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma |
DE10120797B4 (de) | 2001-04-27 | 2005-12-22 | Genovoxx Gmbh | Verfahren zur Analyse von Nukleinsäureketten |
US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US7473767B2 (en) | 2001-07-03 | 2009-01-06 | The Institute For Systems Biology | Methods for detection and quantification of analytes in complex mixtures |
AU2002337030A1 (en) | 2001-08-29 | 2003-03-18 | Genovoxx Gmbh | Method for analyzing nucleic acid sequences and gene expression |
US6927028B2 (en) * | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
JP2003101204A (ja) | 2001-09-25 | 2003-04-04 | Nec Kansai Ltd | 配線基板及び配線基板の製造方法並びに電子部品 |
US20050227231A1 (en) | 2001-10-04 | 2005-10-13 | Dimitri Tcherkassov | Device for sequencing nucleic acid molecules |
DE10149786B4 (de) | 2001-10-09 | 2013-04-25 | Dmitry Cherkasov | Oberfläche für Untersuchungen aus Populationen von Einzelmolekülen |
US6902921B2 (en) | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US20050124022A1 (en) | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
ATE340871T1 (de) * | 2001-12-24 | 2006-10-15 | Wolfgang Prof Holzgreve | Verfahren zur nicht-invasiven diagnose von transplantationen und transfusionen |
WO2003065019A1 (en) | 2002-01-25 | 2003-08-07 | Illumina, Inc. | Sensor arrays for detecting analytes in fluids |
US20090149335A1 (en) | 2002-02-22 | 2009-06-11 | Biolife Solutions Inc. | Method and use of microarray technology and proteogenomic analysis to predict efficacy of human and xenographic cell, tissue and organ transplant |
US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
DE10214395A1 (de) | 2002-03-30 | 2003-10-23 | Dmitri Tcherkassov | Verfahren zur Analyse von Einzelnukleotidpolymorphismen |
CN1633722A (zh) | 2002-04-18 | 2005-06-29 | 日本电池株式会社 | 非水电解质二次电池 |
DE60319719T2 (de) | 2002-09-30 | 2009-03-12 | Novartis Ag | Verfahren zur voraussage der erhöhung von cholesterin während einer immunosuppresiven therapie |
CN101245376A (zh) | 2003-01-17 | 2008-08-20 | 香港中文大学 | 作为妊娠相关病症的诊断标志物的循环mRNA |
ES2338654T5 (es) | 2003-01-29 | 2017-12-11 | 454 Life Sciences Corporation | Amplificación de ácidos nucleicos en emulsión de perlas |
US7025935B2 (en) | 2003-04-11 | 2006-04-11 | Illumina, Inc. | Apparatus and methods for reformatting liquid samples |
US20060263813A1 (en) | 2005-05-11 | 2006-11-23 | Expression Diagnostics, Inc. | Methods of monitoring functional status of transplants using gene panels |
US8150626B2 (en) | 2003-05-15 | 2012-04-03 | Illumina, Inc. | Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns |
US20040241764A1 (en) | 2003-06-02 | 2004-12-02 | Uri Galili | Early detection of recipient's immune response against heart transplant |
US20050181394A1 (en) | 2003-06-20 | 2005-08-18 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
DE10356837A1 (de) | 2003-12-05 | 2005-06-30 | Dmitry Cherkasov | Modifizierte Nukleotide und Nukleoside |
EP1725572B1 (de) | 2003-11-05 | 2017-05-31 | AGCT GmbH | Makromolekulare nukleotidverbindungen und methoden zu deren anwendung |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US7040959B1 (en) | 2004-01-20 | 2006-05-09 | Illumina, Inc. | Variable rate dispensing system for abrasive material and method thereof |
US20050266432A1 (en) | 2004-02-26 | 2005-12-01 | Illumina, Inc. | Haplotype markers for diagnosing susceptibility to immunological conditions |
DE102004009704A1 (de) | 2004-02-27 | 2005-09-15 | Dmitry Cherkasov | Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung |
US7035740B2 (en) | 2004-03-24 | 2006-04-25 | Illumina, Inc. | Artificial intelligence and global normalization methods for genotyping |
SI1730315T1 (sl) | 2004-03-27 | 2010-02-26 | Klein Hanns Georg | Polimorfizmi v genu NOD2/CARD15 |
DE102004025694A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren und Oberfläche zu hochparallelen Analysen von Nukleinsäureketten |
DE102004025695A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren und Oberfläche zur parallelen Sequenzierung von Nukleinsäureketten |
DE102004025745A1 (de) | 2004-05-26 | 2005-12-15 | Cherkasov, Dmitry | Oberfläche für die Analysen an einzelnen Molekülen |
DE102004025744A1 (de) | 2004-05-26 | 2005-12-29 | Dmitry Cherkasov | Oberfläche für die Analysen an einzelnen Nukleinsäuremolekülen |
DE102004025696A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren, Oberfläche und Substrate zu hochparallelen Analysen von Nukleinsäureketten |
DE102004025746A1 (de) | 2004-05-26 | 2005-12-15 | Dmitry Cherkasov | Verfahren, Oberfläche und Substrate zur hochparallelen Sequenzierung von Nukleinsäureketten |
US20060002471A1 (en) | 2004-06-30 | 2006-01-05 | Lippincott Louis A | Motion estimation unit |
US20060024711A1 (en) | 2004-07-02 | 2006-02-02 | Helicos Biosciences Corporation | Methods for nucleic acid amplification and sequence determination |
US7276720B2 (en) | 2004-07-19 | 2007-10-02 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
US20060012793A1 (en) | 2004-07-19 | 2006-01-19 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
US20060019258A1 (en) | 2004-07-20 | 2006-01-26 | Illumina, Inc. | Methods and compositions for detection of small interfering RNA and micro-RNA |
US20060024678A1 (en) | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
ES2534288T3 (es) | 2004-08-03 | 2015-04-21 | Innate Pharma | Composiciones terapéuticas contra el cáncer que seleccionan como objetivo 4Ig-B7-H3 |
WO2007076132A2 (en) | 2005-12-23 | 2007-07-05 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
EP1977234B1 (en) | 2006-01-13 | 2015-11-04 | Indiana University Research & Technology Corporation | Type V collagen for use in a method of treatment of idiopathic pulmonary fibrosis |
US7888017B2 (en) * | 2006-02-02 | 2011-02-15 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
JP2009072062A (ja) * | 2006-04-07 | 2009-04-09 | Institute Of Physical & Chemical Research | 核酸の5’末端を単離するための方法およびその適用 |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
KR100825367B1 (ko) * | 2006-11-07 | 2008-04-28 | 전남대학교산학협력단 | 표지자로서 미토콘드리아 유전자 과변이부위를 이용하는조혈모세포이식 후 생착능 평가방법 및 키트 |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
WO2008079374A2 (en) * | 2006-12-21 | 2008-07-03 | Wang Eric T | Methods and compositions for selecting and using single nucleotide polymorphisms |
PT2121977T (pt) * | 2007-01-11 | 2017-08-18 | Erasmus Univ Medical Center | Captura da conformação cromossómica circular (4c) |
AU2008230813B2 (en) | 2007-03-26 | 2014-01-30 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
PT2557517T (pt) | 2007-07-23 | 2023-01-04 | Univ Hong Kong Chinese | Determinação de um desequilíbrio de sequências de ácido nucleico |
US20090053719A1 (en) * | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
DK2195450T4 (en) | 2007-08-22 | 2016-10-24 | Trovagene Inc | Methods of using miRNA FOR DETECTION IN VIVO cell death |
JP2011515068A (ja) * | 2007-11-08 | 2011-05-19 | ノバルティス アーゲー | 慢性/硬化性同種移植腎症に対する遺伝子発現シグネチャー |
EP2255014A4 (en) | 2008-02-12 | 2011-05-18 | Pacific Biosciences California | COMPOSITIONS AND METHODS FOR USE IN ANALYTICAL REACTIONS |
US20090221620A1 (en) * | 2008-02-20 | 2009-09-03 | Celera Corporation | Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
US8206926B2 (en) | 2008-03-26 | 2012-06-26 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
GB2467704B (en) | 2008-11-07 | 2011-08-24 | Mlc Dx Inc | A method for determining a profile of recombined DNA sequences in T-cells and/or B-cells |
EP2414545B1 (en) | 2009-04-03 | 2017-01-11 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
JP5773535B2 (ja) | 2009-04-24 | 2015-09-02 | ロシュ・イノベーション・センター・コペンハーゲン・アクティーゼルスカブRoche Innovation Center Copenhagen A/S | インターフェロンに非応答性のhcv患者の治療のための医薬組成物 |
CA2779750C (en) | 2009-11-06 | 2019-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive diagnosis of graft rejection in organ transplant patients |
CA2796822C (en) | 2010-05-07 | 2021-10-05 | The Board Of Trustees Of The Leland Standford Junior University | Measurement and comparison of immune diversity by high-throughput sequencing |
WO2012058316A1 (en) | 2010-10-26 | 2012-05-03 | Stanford University | Non-invasive fetal genetic screening by sequencing analysis |
EP2635706B1 (en) * | 2010-11-05 | 2015-04-01 | Centre Hospitalier Universitaire Vaudois | Method for detecting the presence of a dna minor contributor in a dna mixture |
CN103620055A (zh) | 2010-12-07 | 2014-03-05 | 利兰·斯坦福青年大学托管委员会 | 在全基因组规模非侵入性确定亲本单倍型的胎儿遗传 |
CA2863035C (en) | 2012-01-27 | 2023-08-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free rna |
-
2010
- 2010-11-05 CA CA2779750A patent/CA2779750C/en active Active
- 2010-11-05 PT PT108291428T patent/PT2496720T/pt unknown
- 2010-11-05 GB GB1209978.4A patent/GB2488289A/en not_active Withdrawn
- 2010-11-05 PL PL10829142T patent/PL2496720T3/pl unknown
- 2010-11-05 WO PCT/US2010/055604 patent/WO2011057061A1/en active Application Filing
- 2010-11-05 ES ES10829142T patent/ES2821500T3/es active Active
- 2010-11-05 HU HUE10829142A patent/HUE052213T2/hu unknown
- 2010-11-05 EP EP20173563.6A patent/EP3719140A1/en active Pending
- 2010-11-05 CN CN2010800604694A patent/CN102712954A/zh active Pending
- 2010-11-05 US US13/508,318 patent/US8703652B2/en active Active
- 2010-11-05 DK DK10829142.8T patent/DK2496720T3/da active
- 2010-11-05 AU AU2010315084A patent/AU2010315084A1/en not_active Abandoned
- 2010-11-05 EP EP10829142.8A patent/EP2496720B1/en active Active
- 2010-11-05 JP JP2012538027A patent/JP2013509883A/ja active Pending
-
2014
- 2014-02-24 US US14/188,455 patent/US9845497B2/en active Active
-
2016
- 2016-04-04 AU AU2016202076A patent/AU2016202076B2/en active Active
- 2016-04-12 JP JP2016079255A patent/JP6615681B2/ja active Active
-
2017
- 2017-10-19 US US15/788,549 patent/US20180030514A1/en not_active Abandoned
-
2018
- 2018-02-26 AU AU2018201356A patent/AU2018201356B2/en not_active Ceased
- 2018-05-30 JP JP2018102972A patent/JP6772216B2/ja active Active
- 2018-08-23 US US16/110,682 patent/US10329607B2/en active Active
- 2018-08-23 US US16/110,646 patent/US10494669B2/en active Active
-
2019
- 2019-03-13 US US16/352,453 patent/US20190203264A1/en not_active Abandoned
- 2019-03-22 US US16/361,752 patent/US11098350B2/en active Active
- 2019-03-22 US US16/361,741 patent/US10988804B2/en active Active
- 2019-10-08 US US16/596,509 patent/US10982275B2/en active Active
- 2019-10-30 US US16/669,347 patent/US10968479B2/en active Active
-
2020
- 2020-08-20 AU AU2020220162A patent/AU2020220162A1/en not_active Abandoned
- 2020-09-30 JP JP2020164285A patent/JP2021019605A/ja active Pending
-
2021
- 2021-04-20 US US17/235,575 patent/US11384389B2/en active Active
- 2021-05-18 US US17/323,917 patent/US11390918B2/en active Active
-
2022
- 2022-06-08 US US17/835,821 patent/US20220325319A1/en active Pending
- 2022-06-09 US US17/836,671 patent/US11597966B2/en active Active
- 2022-12-02 AU AU2022279551A patent/AU2022279551A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201209978D0 (en) | Non-invasive diagnosis of graft rejection in organ transplant patients | |
GB2450603B (en) | Human pluripotent stem cells and their medical use | |
EP2635185A4 (en) | DETERMINATION OF THE IN VIVO OXYGEN ENRICHMENT OF A TISSUE | |
HK1198773A1 (zh) | 來源於胎盤的貼壁細胞及其在疾病治療中的應用 | |
EP2480165A4 (en) | INTRAVASCULAR BLOOD FILTERS AND METHODS OF USE | |
IL215463A0 (en) | Decellularization and recellularization of organs and tissues | |
EP2414508A4 (en) | BIOREACTOR FOR TISSUE AND ORGAN GRABS AND METHOD OF OPERATION | |
EP2498796A4 (en) | TREATMENT OF HEART DISEASES | |
IL226026A0 (en) | A monitoring device for non-invasive modulation of the blood glucose level in a living body | |
EP2257155A4 (en) | KRYOCONSERVATION OF BIOLOGICAL CELLS AND TISSUE | |
EP2358301A4 (en) | REGENERATIVE TISSUE GRAFT AND METHODS OF MAKING THE SAME | |
HK1169455A1 (zh) | 阿爾茨海默病的診斷和治療 | |
EP2335073A4 (en) | IN VIVO DIAGNOSIS AND TREATMENT OF BIOFILM INFECTIONS | |
PL3378930T3 (pl) | Rusztowanie dla wzrostu tkanki in vivo | |
EP2485741A4 (en) | PREPARATION AND USE OF STROMAL CELLS FOR THE TREATMENT OF CARDIAC DISORDERS | |
EP2350001A4 (en) | NEW BENZYLIDENE INDOLINOES AND THEIR MEDICAL AND DIAGNOSTIC USES | |
EP2351508A4 (en) | APPARATUS FOR OBSERVING LIVING BODIES | |
PL2477666T3 (pl) | Zszywalny konstrukt przeszczepu tkankowego do rekonstrukcji organu ludzkiego lub zwierzęcego | |
EP2203747A4 (en) | DIAGNOSIS AND TREATMENT OF A TISSUE WITH DISEASE AND LOSS | |
IL217133A0 (en) | Diagnosis and treatment of autoimmune demyelinating diseases | |
EP2491143A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF GENETIC RETINOPATHY | |
HU0900195D0 (en) | Diagnosis and treatment of gluten-induced autoimmune diseases | |
EP2517013A4 (en) | DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH DEFICIENT REVERSE CHOLESTER INTRANSPORT | |
GB0903858D0 (en) | Diagnosis of disease | |
GB201017857D0 (en) | Methods for diagnosis and methods of treatment |